UniProt ID | AOFB_HUMAN | |
---|---|---|
UniProt AC | P27338 | |
Protein Name | Amine oxidase [flavin-containing] B | |
Gene Name | MAOB | |
Organism | Homo sapiens (Human). | |
Sequence Length | 520 | |
Subcellular Localization |
Mitochondrion outer membrane Single-pass type IV membrane protein Cytoplasmic side. |
|
Protein Description | Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine.. | |
Protein Sequence | MSNKCDVVVVGGGISGMAAAKLLHDSGLNVVVLEARDRVGGRTYTLRNQKVKYVDLGGSYVGPTQNRILRLAKELGLETYKVNEVERLIHHVKGKSYPFRGPFPPVWNPITYLDHNNFWRTMDDMGREIPSDAPWKAPLAEEWDNMTMKELLDKLCWTESAKQLATLFVNLCVTAETHEVSALWFLWYVKQCGGTTRIISTTNGGQERKFVGGSGQVSERIMDLLGDRVKLERPVIYIDQTRENVLVETLNHEMYEAKYVISAIPPTLGMKIHFNPPLPMMRNQMITRVPLGSVIKCIVYYKEPFWRKKDYCGTMIIDGEEAPVAYTLDDTKPEGNYAAIMGFILAHKARKLARLTKEERLKKLCELYAKVLGSLEALEPVHYEEKNWCEEQYSGGCYTTYFPPGILTQYGRVLRQPVDRIYFAGTETATHWSGYMEGAVEAGERAAREILHAMGKIPEDEIWQSEPESVDVPAQPITTTFLERHLPSVPGLLRLIGLTTIFSATALGFLAHKRGLLVRV | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MSNKCDVVV ------CCCCCCEEE | 45.02 | 11049757 | |
26 | Phosphorylation | AAKLLHDSGLNVVVL HHHHHHHCCCCEEEE | 34.14 | 28258704 | |
43 | Phosphorylation | RDRVGGRTYTLRNQK CCCCCCEEEEECCCE | 24.92 | - | |
44 | Phosphorylation | DRVGGRTYTLRNQKV CCCCCEEEEECCCEE | 11.47 | 24719451 | |
45 | Phosphorylation | RVGGRTYTLRNQKVK CCCCEEEEECCCEEE | 20.73 | 24719451 | |
52 | Acetylation | TLRNQKVKYVDLGGS EECCCEEEEEECCCC | 46.74 | - | |
52 | Ubiquitination | TLRNQKVKYVDLGGS EECCCEEEEEECCCC | 46.74 | 21906983 | |
53 | Phosphorylation | LRNQKVKYVDLGGSY ECCCEEEEEECCCCC | 11.37 | - | |
59 | Phosphorylation | KYVDLGGSYVGPTQN EEEECCCCCCCCHHH | 18.17 | 28857561 | |
60 | Phosphorylation | YVDLGGSYVGPTQNR EEECCCCCCCCHHHH | 16.83 | - | |
64 | Phosphorylation | GGSYVGPTQNRILRL CCCCCCCHHHHHHHH | 32.33 | 28857561 | |
73 | Ubiquitination | NRILRLAKELGLETY HHHHHHHHHHCCCEE | 59.05 | 21906983 | |
81 | Ubiquitination | ELGLETYKVNEVERL HHCCCEEEHHHHHHH | 46.10 | 21906983 | |
93 | Ubiquitination | ERLIHHVKGKSYPFR HHHHHHHCCCCCCCC | 57.15 | - | |
131 | Phosphorylation | DMGREIPSDAPWKAP HHCCCCCCCCCCCCC | 52.66 | 22673903 | |
136 | Ubiquitination | IPSDAPWKAPLAEEW CCCCCCCCCCCHHHH | 38.78 | 21906983 | |
181 | Phosphorylation | TAETHEVSALWFLWY CCCHHHHHHHHHHHH | 18.05 | 26074081 | |
188 | Phosphorylation | SALWFLWYVKQCGGT HHHHHHHHHHHCCCE | 10.42 | 26074081 | |
195 | Phosphorylation | YVKQCGGTTRIISTT HHHHCCCEEEEEEEC | 9.74 | 26074081 | |
196 | Phosphorylation | VKQCGGTTRIISTTN HHHCCCEEEEEEECC | 24.12 | 26074081 | |
200 | Phosphorylation | GGTTRIISTTNGGQE CCEEEEEEECCCCCE | 27.14 | 26074081 | |
201 | Phosphorylation | GTTRIISTTNGGQER CEEEEEEECCCCCEE | 17.55 | 26074081 | |
202 | Phosphorylation | TTRIISTTNGGQERK EEEEEEECCCCCEEE | 25.69 | 26074081 | |
209 | Ubiquitination | TNGGQERKFVGGSGQ CCCCCEEEEECCCCH | 43.58 | 21906983 | |
214 | Phosphorylation | ERKFVGGSGQVSERI EEEEECCCCHHHHHH | 21.81 | 26074081 | |
218 | Phosphorylation | VGGSGQVSERIMDLL ECCCCHHHHHHHHHH | 17.17 | 22210691 | |
230 | Ubiquitination | DLLGDRVKLERPVIY HHHCCCCCCCCCEEE | 45.59 | 21906983 | |
337 | Phosphorylation | DTKPEGNYAAIMGFI CCCCCCCHHHHHHHH | 14.31 | - | |
370 | Ubiquitination | KLCELYAKVLGSLEA HHHHHHHHHHHCHHH | 25.16 | - | |
374 | Phosphorylation | LYAKVLGSLEALEPV HHHHHHHCHHHHCCC | 20.90 | 20833797 | |
383 | Phosphorylation | EALEPVHYEEKNWCE HHHCCCCCCCCCCCC | 26.47 | - | |
397 | Other | EEQYSGGCYTTYFPP CHHCCCCCCCCCCCC | 2.88 | 11753429 | |
397 | S-8alpha-FAD cysteine | EEQYSGGCYTTYFPP CHHCCCCCCCCCCCC | 2.88 | - | |
456 | Ubiquitination | EILHAMGKIPEDEIW HHHHHCCCCCHHHHH | 41.84 | 21906983 | |
465 | Phosphorylation | PEDEIWQSEPESVDV CHHHHHHCCCCCCCC | 39.87 | 28857561 | |
469 | Phosphorylation | IWQSEPESVDVPAQP HHHCCCCCCCCCCCC | 34.04 | 28857561 | |
478 | Phosphorylation | DVPAQPITTTFLERH CCCCCCCCHHHHHHC | 26.85 | 27251275 | |
479 | Phosphorylation | VPAQPITTTFLERHL CCCCCCCHHHHHHCC | 19.10 | 27251275 | |
480 | Phosphorylation | PAQPITTTFLERHLP CCCCCCHHHHHHCCC | 19.99 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AOFB_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AOFB_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AOFB_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
SRPK1_HUMAN | SRPK1 | physical | 21988832 | |
NFYB_HUMAN | NFYB | physical | 21988832 |
Kegg Disease | |
---|---|
There are no disease associations of PTM sites. | |
OMIM Disease | |
There are no disease associations of PTM sites. | |
Kegg Drug | |
D00095 | Adrenaline (JP16); Epinephrine (USP/INN); Adrenalin (TN); Auvi-q (TN); Epipen (TN) |
D00346 | Isoniazid (JP16/USP/INN); Laniazid (TN) |
D00505 | Phenelzine sulfate (USP); Nardil (TN) |
D00633 | Dopamine hydrochloride (JP16/USP); Actopamin (TN); Intropin (TN) |
D00785 | Selegiline hydrochloride (JAN/USP); Eldepryl (TN) |
D00826 | Tranylcypromine sulfate (USP XXI); Parnate (TN) |
D01097 | Lazabemide hydrochloride (JAN/USAN); Tempium (TN) |
D01304 | Amezinium metilsulfate (JAN); Risumic (TN) |
D01501 | Isoniazid calcium pyruvinate (JAN); Pyruvic acid calcium isoniazid |
D01888 | Safrazine hydrochloride (JAN) |
D02002 | Isoniazid sodium methanesulfonate hydrate (JAN); Isoniazid sodium methanesulfonate monohydrate; Ison |
D02562 | Rasagiline mesylate (USAN); Azilect (TN) |
D02564 | Pargyline hydrochloride (USAN); Eutonyl (TN) |
D02579 | Iproniazid (INN) |
D02580 | Isocarboxazid (INN); Marplan (TN) |
D03239 | Ladostigil tartrate (USAN) |
D03409 | Caroxazone (USAN/INN) |
D03731 | Selegiline (USAN/INN); Emsam (TN) |
D03733 | Mofegiline hydrochloride (USAN) |
D04092 | Etryptamine acetate (USAN) |
D04681 | Lazabemide (USAN/INN) |
D05033 | Milacemide hydrochloride (USAN) |
D07337 | Nialamide (INN); Niamid (TN) |
D07338 | Iproclozide (INN); Iproclozide (TN) |
D07870 | Dopamine (INN); Medopa (TN) |
D08085 | Iproniazid phosphate; Marsilid (TN) |
D08349 | Phenelzine (BAN) |
D08453 | Pargyline (INN) |
D08469 | Rasagiline (USAN/INN); Azilect (TN) |
D08625 | Tranylcypromine (INN); Parnate (TN) |
D09773 | Isoniazid glucuronate sodium (JAN) |
D10158 | Safinamide (USAN/INN) |
D10191 | Safinamide mesylate (USAN) |
DrugBank | |
DB00915 | Amantadine |
DB00182 | Amphetamine |
DB00988 | Dopamine |
DB01363 | Ephedra |
DB03147 | Flavin adenine dinucleotide |
DB00614 | Furazolidone |
DB01247 | Isocarboxazid |
DB00601 | Linezolid |
DB01577 | Methamphetamine |
DB01171 | Moclobemide |
DB08804 | Nandrolone decanoate |
DB00184 | Nicotine |
DB01626 | Pargyline |
DB00780 | Phenelzine |
DB00191 | Phentermine |
DB00721 | Procaine |
DB01367 | Rasagiline |
DB01037 | Selegiline |
DB01104 | Sertraline |
DB00752 | Tranylcypromine |
DB00909 | Zonisamide |
loading...